The effects of the drug and placebo were evaluated using a set of neuropsychological tests to assess behaviour.
It was observed that patients treated with LAC demonstrated reduced hyperactive behaviour and increased attention, without exhibiting any side effects. The patients treated with the placebo also showed reduced hyperactive behaviour, though not nearly to the extent as the LAC-treated patients.
According to the researchers, the patients treated with LAC also had significantly improved social ability compared to the placebo-treated group. Both groups took intelligence tests, but LAC did not improve overall intellectual functioning.
“We propose that LAC be recommended as a treatment of ADHD in FXS children, since it effectively reduces hyperactive behavior and improves social abilities without adverse side effects,” say the authors.
They suggested that the findings might be applicable to autistic children, who also do not easily tolerate stimulants.
Source-ANI
SRM/L